The Parkinson's disease market is expected to grow to $12.8 billion by 2028.

LAS VEGAS, July 11, 2023 (Newswire.com) - Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has successfully completed a dose response study in rodents at the University of Lethbridge that supports Gb Sciences' cannabinoid-based therapy for Parkinson's disease. The study has established dose ranges and the corresponding times to onset and duration of action in a rodent model. In addition to the dosage range findings, this study demonstrated that Gb Sciences' Parkinson's disease formulations were well tolerated, and there were no adverse effects. As early as next year, Gb Sciences plans on filing an Investigational New Drug Application to begin first-in-human clinical trials. As the second most common neurodegenerative disease, the market for Parkinson's disease (PD) treatments is expected to grow to $12.8 billion by 2028.

"Gb Sciences is developing a first-in-class, cannabinoid-based treatment for the motor symptoms of Parkinson's disease. From this critical study, we have established ranges for the dosage and duration of action in a rodent model that helps us to predict the corresponding and appropriate dose range and duration of action of Gb Sciences' Parkinson's disease therapies for our first-in-human trial," explained Dr. Andrea Small-Howard, President, Chief Science Officer, and board member of Gb Sciences, Inc. "Additionally, this study augments our safety data and suggests that our novel therapeutic may also help alleviate the significant non-motor symptoms of the disease such as problems with sleeping and appetite." 

The dose response study in rodents performed at the University of Lethbridge helps to establish the correct dosing of Gb Sciences' cannabinoid-containing Parkinson's formulations for a first-in-human trial. Dr. Robert Sutherland, Ph.D., FRSC, Professor and Chair of the Department of Neuroscience at the University of Lethbridge, Board of Governors Research Chair in Neuroscience, and Director of the Canadian Centre for Behavioral Neuroscience, used deep learning models to analyze the rich data sets from their "Home Cage Small World" behavioral assessments of rodents with video cameras and Artificial Intelligence, using a system developed by Neurocage Systems Ltd. Future studies confirming the mechanism of action of these cannabinoid-based Parkinson's formulations are planned with Dr. Sutherland's research group at the University of Lethbridge using their state-of-the-art behavioral measurement methods for rodents.

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The 'plant-inspired' active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' intellectual property portfolio contains six U.S. and five foreign patents issued, 1 U.S. and 3 foreign patents allowed; as well as 18 U.S. and 55 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences' lead program for Parkinson's disease is being prepared for a first-in-human clinical trial. Gb Sciences' formulations for chronic pain, anxiety and depression are currently in preclinical animal studies with researchers at the National Research Council of Canada (NRC). The company received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. The Company has also received positive preclinical proof-of-concept data supporting its phytochemical mixtures for the treatment of anxiety. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

About the University of Lethbridge

Founded in 1967, on traditional Blackfoot land, the University of Lethbridge is home to approximately 8,000 undergraduate and graduate students from around the world. With campuses in Lethbridge and Calgary, ULethbridge is one of Canada's top universities and leading research institutions. Its Blackfoot name, gifted by Elder Bruce Wolf Child, is Iniskim, meaning Sacred Buffalo Stone. The University of Lethbridge is a board-governed public post-secondary institution operating in Alberta as a comprehensive academic and research university under the authority of the Post-secondary Learning Act.

ULethbridge serves the people of southern Alberta through programs, research and creative activity that contribute to economic and social prosperity locally and globally. Founded on the principles of liberal education, the University of Lethbridge is broad in scope while promoting excellence in undergraduate and graduate education that prepares students to understand and address an increasingly complex and interconnected world. The University fosters a learning community that meets the educational and personal growth needs of its students by emphasizing teaching excellence, exposure to research, information literacy, interaction with professors and instructors, effective academic advising, applied learning opportunities and career counseling, as well as a spectrum of cultural, recreational and extracurricular opportunities. To learn more, visit www.ulethbridge.ca.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Contact Information:
Alexis Quintal
[email protected]


Original Source: Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge

As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its efforts.

GRAND RAPIDS, Mich., July 11, 2023 (Newswire.com) - About 95% of American teens report using a social media platform, with more than a third saying they use it "almost constantly." Studies show social media use may affect young people's brain development and make them less happy as teenagers—prompting the U.S. Surgeon General in May to issue a public health advisory on social media use. Mentavi Health has added a validated assessment tool for measuring problematic social media use to its standard ADHD Online assessment process. 

Mentavi Health is the parent company of ADHD Online, the industry leader in virtual ADHD assessment and patient care plans. ADHD Online offers HIPAA-secured ADHD assessments online with certified results from licensed psychologists in all 50 states. 

The Bergen Social Media Addiction Scale (BSMAS), a six-item questionnaire, is a validated assessment tool used in large- and small-scale medical studies. Mentavi Health added the BSMAS at the recommendation of new Chief Medical Officer Dr. Barry K. Herman to help patients and others raise their awareness of their habits related to social media.

Herman said the Surgeon General's Advisory was a wake-up call, informing people that they need to pay more attention to the detrimental effects of social media.

"The Surgeon General's report underscored that urgent action is needed to understand and minimize harm, creating safer online environments for young people. Our team embraced this need and has fully integrated the Bergen Social Media Addiction Scale into our standard ADHD Online assessment process," Herman said.

"Although social media addiction does not yet have a formal diagnosis in the industry, our ADHD assessment will now also provide pertinent information on patient tendencies and risks in these areas, in keeping with our philosophy of providing optimal self-awareness," he said.

The Surgeon General's report notes that harmful effects of social media addiction include increased anxiety, depression, poor concentration, impaired academic and work performance, and decreased overall satisfaction with life. "This is a growing concern among people of all ages, in an area where many have little insight into their behaviors and where consequences can be significant," Herman said.  

Among the findings in the report, which draws on more than 100 studies from pediatricians, psychologists and other experts: 

Children and young adults spend an average of three hours per day on social media platforms.

Social media is designed to be addictive, with features like endless scrolling and notifications that grab attention. 

The appeal of social media is linked to innate social instincts and the release of dopamine in the brain, which can lead to habit formation and addiction.

Harmful effects of social media addiction include increased anxiety and depression, disrupted sleep, inability to concentrate, poor academic and work performance, and less overall satisfaction with life

Risk factors for social media addiction include poor emotion regulation, low self-esteem, and limited coping skills.

In addition to preventive measures like digital detoxes and reducing social media usage, treatment for social media addiction may involve various approaches, such as therapy, counseling, support groups, and addressing underlying mental health issues. 

Mentavi Health believes ADHD Online's ability to assess people's problematic social media use can be a valuable addition to its mission of making better mental and emotional health available to all, regardless of location or physical access to healthcare professionals. 

"We hope that with the addition of the BSMAS, we will be able to help even more people develop a better understanding of their overall mental health and to assist our licensed professionals to diagnose, care and connect people with the treatment they need and deserve," said Herman.

For more information, please visit https://adhdonline.com.

About ADHD Online  

ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they are. The ADHD Online team is filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. ADHD Online is active in all 50 states. 

Contact Information:
Mike Albanese
[email protected]
Related Images


Original Source: ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform

ST. LOUIS, July 10, 2023 (Newswire.com) - American Medical Administrators, Inc., (American Medical), a new and innovative healthcare services company focused on the development and commercialization of providing greater access to healthcare for underserved communities across America, announced today, Dr. Jon Manzer, MD, has joined the company as a Primary Care Physician at American Medical Missouri. Manzer Family Medicine was one of the largest independent primary care and urgent care practices in Western MO, also reaching into Kansas.

"This is what independent physicians need, what we have been waiting for; this is bigger than me, we are going to build a legacy," said Dr. Manzer. By joining American Medical, Dr. Manzer is now able to expand his diagnostic and procedural capabilities by utilizing American Medical's Radiology and Surgical offerings in all of his locations. Dr. Manzer is actively opening new urgent care locations and is in the process of expanding his staff, creating new employment opportunities. 

"We are converting Dr. Manzer's operations into a regional health center where patients can access the most advanced and affordable healthcare and diagnostic services directly in their local communities. When American Medical is done with our implementation, we will have a regional hub that offers advanced diagnostic and specialty services, becoming a true center for functional health," says Dr. Abdullah Arshad, American Medical's COO. 

About American Medical 

"American Medical Administrators, Inc." is a vertically integrated healthcare system committed to empowering physicians and clinicians with efficient state-of-the-art diagnostic and therapeutic tools to provide all patients in their local communities access to advanced, affordable, and comprehensive care. American Medical offers walk-in urgent care services combined with traditional family practice medicine and multi-specialty ambulatory surgical services. AMA is a physician-driven company designed with a patient-centric model, with the simple goal of providing the best healthcare quality in the 21st Century. AMA championed the concept that Superior Patient Outcomes can be Driven by Innovative Technology. 

For additional information about American Medical, please visit AMadministrators.com. 

Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including, without limitation, those regarding our expectations to commercialize of AMA. Forward-looking statements involve inherent risks and uncertainties, and important factors could cause actual results to differ materially from those anticipated, including the factors identified under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our financial reports for this fiscal year which are accessible on the Investors page of our website at www.AMadministrators.com. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them in light of new information or future events. 

Investor and Media Contact 

Nicholas Destefane 

Managing Director, 

Investor Relations 

1-800-961-4826

[email protected]

10345 Watson Road

Saint Louis, MO 63127-1105

Contact Information:
Nicholas Destefane
Managing Director
[email protected]
1(800)961-4826


Original Source: American Medical Administrators, Inc. Announces the Acquisition of Manzer Family Medicine, LLC, and Dr. Jon Manzer Joining the Organization

This new CPR training facility serves San Jose, Milpitas, Sunnyvale, and the South Bay flexible and affordable CPR certification courses to the public.

SUNNYVALE, Calif., July 10, 2023 (Newswire.com) - Safety Training Seminars, an official American Heart Association^© (AHA) Training Center in California, has opened a new training center in Sunnyvale, CA. The new location builds on Safety Training Seminars' reputation of offering flexible, affordable certification paths in CPR, BLS, ACLS, and PALS across California. 

The CPR training center is located at 830 Stewart Drive, Suite 133, Sunnyvale, CA 94085, and is centrally located near San Jose, CA. The location serves medical and healthcare professionals in Santa Clara County who do not want to drive into San Jose for a certification course. This new office offers a flexible schedule of daily and weekend classes to meet the needs of busy professionals.

Safety Training Seminars' training programs in Sunnyvale include new and renewal certification courses in CPR, BLS, ACLS, and PALS. Each class offers a flexible blend of online learning components and on-site skills testing. 

ACLS courses offer initial and renewal certification in Advanced Cardiovascular Life Support. Attendees learn about continuous, high-quality CPR and how to administer it correctly. The program is designed for professionals responding to cardiopulmonary arrest or other cardiovascular emergencies. 

CPR and First-aid classes are designed for a wide variety of participants who may respond to emergencies, including teachers, babysitters, grandparents, supervisors, and others. Students learn proper CPR skills for infants, children, and adults. The course covers choke saving, AED use, bleeding treatment, seizures, burn treatment, and more. All students will receive the official American Heart Association CPR and First-aid certification after the course. This course is valid for CA childcare providers. 

BLS CPR Certification courses are offered for new or renewal certification. They help attendees identify and respond to life-threatening emergencies, properly administer chest compressions, perform ventilation, and AED use.

PALS Courses are designed for those working in emergency response, emergency medicine, intensive care, and critical care units. Each course is designed to meet the criteria for initial or renewal certification. Pediatric Advanced Life Support courses help attendees recognize emergencies and administer lifesaving treatments in infants and children. 

"An emergency situation can arise at any time, and our goal is to equip as many Bay Area residents as possible with the lifesaving skills and confidence to react when seconds count," said Laura Seidel, owner of Safety Training Seminars. 

Safety Training Seminars has provided crucial courses for certification and lifesaving training since 1989. The woman-owned company offers certification classes in CPR, First Aid, BLS, ACLS, PALS, NRP, and EMSA Childcare. With over 40 locations across Northern California, Safety Training Seminars provides affordable, flexible training, furnished with the most up-to-date training resources and equipment. To learn more about CPR and First-aid training in Sunnyvale, San Jose, and other locations across California, visit www.bayareacpr.org

Contact Information:
Danielle Bell
General Manager
[email protected]
415-437-1600


Original Source: Safety Training Seminars Opens a New CPR Certification Training School in Sunnyvale, CA